[Form 4] The Chemours Company Insider Trading Activity

Rhea-AI Filing Summary

The Chemours Company reported an insider transaction by Shane Hostetter, its Chief Financial Officer. The filing shows 3,021 common shares were withheld to satisfy tax obligations on vesting restricted stock units and dividend equivalent units. The report indicates these withholding transactions were exempt under Rule 16b-3 and that no shares were sold in connection with the withholding.

The filing lists a per-share price of $12 for the withheld shares and shows total beneficial ownership following the transaction of 57,115.1539 shares, which the filer states includes directly owned shares, restricted stock units and dividend equivalent units.

Insights

Financial Analyst

Routine tax-withholding on vested equity; limited investor impact.

The report documents a common, administrative transaction where 3,021 shares were automatically withheld to cover tax liabilities on vested restricted stock units and dividend equivalent units. The filing explicitly states that no shares were sold and that the transaction is exempt under Rule 16b-3, which typically preserves the issuer and reporting person's exemption from short-swing profit recapture. Post-transaction beneficial ownership is reported as 57,115.1539 shares, aggregating directly held shares and unexercised/vested awards. This is a routine insider administrative adjustment and does not reflect a change in economic exposure beyond the vesting event itself.

Corporate Governance Expert

Governance controls functioning; disclosure aligns with Section 16 reporting norms.

The filing discloses an internal tax-withholding action for the CFO’s equity awards rather than an open-market disposition. The explanatory note confirms the withholding satisfies tax obligations on vesting awards and affirms the Rule 16b-3 exemption, indicating adherence to standard Section 16 procedures for equity compensation. The registry of 57,115.1539 shares as beneficial ownership, including restricted stock units and dividend equivalents, provides transparency on the reporting person’s aggregate exposure as of the report. From a governance standpoint, this is a routine, properly-exempted administrative transaction with no apparent compliance concern disclosed in the form.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HOSTETTER SHANE

(Last) (First) (Middle)

C/O THE CHEMOURS COMPANY

1007 MARKET STREET

(Street)

WILMINGTON DE 19801

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Chemours Co [ CC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/06/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/06/2025		F(1)		3,021	D	$12	57,115.1539(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares automatically withheld to satisfy tax obligations on vesting restricted stock units and dividend equivalent units. Transactions are exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold.

2. Includes directly owned shares, restricted stock units and dividend equivalent units.

	/s/ Eric Stein, Attorney-in-Fact	08/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Chemours (CC) Form 4 report for Shane Hostetter?

The filing reports that 3,021 common shares were automatically withheld to satisfy tax obligations on vested restricted stock units and dividend equivalent units.

Did Shane Hostetter sell any Chemours shares in this transaction (CC)?

No. The filing explicitly states no shares were sold; the transaction was a withholding to cover taxes on vesting awards.

What is the beneficial ownership reported after the transaction for the reporting person?

The filing reports total beneficial ownership of 57,115.1539 shares, which the filer says includes directly owned shares, restricted stock units and dividend equivalent units.

Was the transaction exempt from Section 16(b) short-swing rules?

Yes. The form states the transactions are exempt pursuant to Rule 16b-3.

What price is listed for the withheld shares in the Form 4?

The filing shows a per-share amount of $12 associated with the withheld shares as reported in the table.